Immix Biopharma, Inc. Share Price
NASDAQ: IMMX | Small CapImmix Biopharma, Inc. Stock Performance
Immix Biopharma, Inc. Share Price Today
As of 18 September 2026, Immix Biopharma, Inc.'s share price is $12.71. The stock opened at $12.13, compared to its previous close of $11.91. During today's trading session, Immix Biopharma, Inc.'s share price traded between $12.13 and $12.72, with an average price of $12.43. Over the past 52 weeks, the stock has recorded a high of $15.09 and a low of $1.97. In terms of performance, Immix Biopharma, Inc.'s share price has risen by 39.27% over the last six months and is up 508.37% on a year-on-year basis.
Immix Biopharma, Inc. Share Price Chart
Immix Biopharma, Inc. Quarterly Profit & Loss
All figures in USD
Immix Biopharma, Inc. Annual Profit & Loss
All figures in USD
About Immix Biopharma, Inc.
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Immix Biopharma, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $14.03 | $12.71 | -11.06% |
Aug 2026 | $8.31 | $14.29 | +71.65% |
Jul 2026 | $10.19 | $8.32 | -19.10% |
Jun 2026 | $8.93 | $10.29 | +14.52% |
May 2026 | $8.91 | $8.98 | +0.50% |
Apr 2026 | $9.43 | $8.94 | -2.08% |
Mar 2026 | $8.11 | $9.13 | +13.42% |
Feb 2026 | $5.78 | $8.05 | +38.44% |
Jan 2026 | $5.24 | $5.82 | +11.61% |
Dec 2025 | $4.22 | $5.21 | +22.01% |
Nov 2025 | $3.77 | $4.27 | +12.66% |
Oct 2025 | $2.10 | $3.79 | +81.34% |